BACKGROUND: Previous studies on immunosuppression and anti-rejection after organ
transplantation mainly focused on effects of T lymphocytes-mediated immune response
and immunosuppressive agents on T lymphocytes. Effects of dendritic cells were
unclear. The manifestation and mechanism of immunosuppressive agent effects on
dendritic cells are not identical.
OBJECTIVE: To compare the effects of different immunosuppressive agents on
expression and function of costimulatory molecules of dendritic cells, and to
explore the mechanism of action of immunosuppressive agents.
METHODS: 20 μg/L rapamycin, 0.04 mg/L mycophenolate, 10 μg/L tacrolimus and 1 mg/L
cyclosporine A were separately added during bone marrow cells of C57BL/6 mice were
differentiated into dendritic cells.
RESULTS AND CONCLUSION: Flow cytometry results revealed that CD40 expression in each
group: rapamycin < tacrolimus < cyclosporine A < mycophenolate mofetil (P < 0.01);
CD86 expression: rapamycin < tacrolimus < cyclosporine A = mycophenolate mofetil (P
< 0.01). There was no significant difference in CD80, CD11c and major
histocompatibility complex II expression among groups (P > 0.05). One-way mixed
lymphocyte reaction results displayed dendritic cell costimulatory T cell proliferation in each group:
rapamycin < mycophenolate mofetil < tacrolimus = cyclosporine A (P < 0.05). The
results confirmed that rapamycin, tacrolimus, cyclosporine A, and mycophenolate
mofetil exerted immunosuppression by suppressing CD40 and CD86, especially
rapamycin. Above medicines do not noticeably inhibit major histocompatibility
complex II expression, but suppress T cell proliferation, and the inhibitory effect
of rapamycin on cell proliferation is strongest.